Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 15Esophageal Neoplasms 10Colorectal Neoplasms 10Rectal Neoplasms 7Adenocarcinoma Of Esophagus 7Stomach Neoplasms 6Colonic Neoplasms 5Gastroesophageal Reflux 4Colorectal Neoplasms, Hereditary Nonpolyposis 3Precancerous Conditions 2Pathologic Complete Response 2Esophageal Squamous Cell Carcinoma 2Carcinoma 2Adenomatous Polyposis Coli 2Adenocarcinoma 2Stomach Ulcer 1Stomach Diseases 1Recurrence 1Polyps 1Polyposis, Gastric 1Pancreatic Pseudocyst 1Neoplasms 1Metaplasia 1Locally Advanced Pancreatic Cancer 1Hyperplasia 1Gastroparesis 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Gastric Outlet Obstruction 1Fistula 1

Interventions

chlorhexidine gluconate 1Omeprazole 1Lansoprazole 1Esomeprazole 1Endoscopy 1Dexlansoprazole 1Clopidogrel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophagitis, Peptic × Endoscopy × Gastrointestinal × Clear all
NCT03388047 2021-04-28

MuSE

University of Cambridge

Phase NA Completed
20 enrolled
Gastrointestinal

Adenocarcinoma, Barrett Esophagus, Esophageal Neoplasms, Esophagitis, Peptic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡